ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

LLOY Lloyds Banking Group Plc

55.52
0.50 (0.91%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lloyds Banking Group Plc LSE:LLOY London Ordinary Share GB0008706128 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.91% 55.52 55.48 55.50 55.56 54.96 55.00 208,227,475 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Commercial Banks, Nec 23.74B 5.46B 0.0859 6.46 35.28B
Lloyds Banking Group Plc is listed in the Commercial Banks sector of the London Stock Exchange with ticker LLOY. The last closing price for Lloyds Banking was 55.02p. Over the last year, Lloyds Banking shares have traded in a share price range of 39.55p to 55.56p.

Lloyds Banking currently has 63,569,225,662 shares in issue. The market capitalisation of Lloyds Banking is £35.28 billion. Lloyds Banking has a price to earnings ratio (PE ratio) of 6.46.

Lloyds Banking Share Discussion Threads

Showing 350951 to 350964 of 427200 messages
Chat Pages: Latest  14040  14039  14038  14037  14036  14035  14034  14033  14032  14031  14030  14029  Older
DateSubjectAuthorDiscuss
16/3/2021
13:07
Anyone watch panaroma yesterday Government buddies made a killing also all PPE comes from China as they good at making things now
pal44
16/3/2021
12:30
Elbee, the first no-go area that comes to mind are your brain cells, which appear to have rejected all forms of nutrition.
psychochopper
16/3/2021
12:28
as I said yesterday


I feel for the Europeans


LED BY DONKEYS

sentimental rules
16/3/2021
12:25
most of you will rue the day you wrote such dangerous and misleading rubbish when the UK becomes a no go area because of the non immune vaccinated who will generate massive variants and contaminate everyone.

watch this space if you are still alive

mr.elbee
16/3/2021
12:14
Be aware Their are over 15000 scams working in Africa to steal your money They work to steal .Lazy scum
portside1
16/3/2021
12:13
Bloomberg are generally slanted towards all things European, especially where the U.K. are involved. Further, Sam Fizeli (referred to in the article) was originally slightly AZN-sceptic (was not happy they had little over 65s data).

So this is a good and balanced read.

Slamming Brakes on AstraZeneca Has Side Effects: Lionel Laurent
2021-03-16 08:10:22.63 GMT


By Lionel Laurent
(Bloomberg Opinion) -- Thierry Breton, the European Union
commissioner in charge of fixing the bloc’s mass vaccination
campaign, likes to start his day with a call to AstraZeneca Plc
boss Pascal Soriot to keep tabs on the supply of Covid-19
vaccines critical to immunizing the bloc’s population and
reopening its economy by the summer.
The conversation’s been tense for a while, but surely more
so this week. Countries across Europe including France, Germany
and Italy have suspended vaccination with AstraZeneca’s Covid-19
shot following reports of serious blood clotting. The European
Medicines Agency still says the benefits of being vaccinated
outweigh the risks. It’s looking into the reports. The nations
hitting pause say they’re doing it for purely “precautionary
reasons — to be safe rather than sorry.
This is a complex issue, with few easy answers. The EU is
facing a new wave of Covid-19 infections, and the AstraZeneca
vaccine is a critical weapon against the coronavirus. Any
interruption to the rollout is an immediate setback. The need to
protect citizens from danger also means health authorities are
“stuck between a rock and a hard place,” as Bloomberg
Intelligence’s Sam Fazeli puts it.
If this uncertain situation isn’t resolved quickly, the
risk is that the precautionary principle used to explain such
decision-making willdo more harm than good, especially at a time
when more lockdowns loom.
Investigating reported side-effects and severe events is
vital in a vaccination campaign, butthere’s a real question as
to whether slamming on the brakes in this instance unnecessarily
downplays the data we already have. As of March 10, 30 cases of
blood-clot events had been reported among close to 5 million
Europeans given the AstraZeneca shot, according to the
Amsterdam-based EMA, or 0.0006%.
AstraZeneca on Monday said there was no evidence of
increased blood-clot risk among those vaccinated in the U.K. and
EU, and that in clinical trials the number of events was
actually lower in those vaccinated compared with the placebo
group.
There’s a fine line between precaution and what the
University of Copenhagen’s Ezio Di Nucci, an expert on medical
ethics, warns is a “zero-riskR21; worldview — one that might bring
second-guessing at every turn in the global vaccination
campaign.
One could potentially argue that a belt-and-braces approach
means going above and beyond to preserve public trust,
especially in countries with traditionally high vaccine
hesitancy like France. Any error might prove fateful to the
public take-up of Covid-19 vaccines.
Yettheir caution runs directly counter to explicit warnings
by public-health regulators like the EMA and the World Health
Organization of the risk of delaying inoculations, bringing more
cases and deaths. And politicians’ shifting positions on the
safety and efficacy of vaccines like AstraZeneca’s can even
erode the confidence they’re working so hard to win over.
While this precautionary urge comes “from the right place,”
according to Maxwell Smith, assistant professor at Western
University in Canada, the threshold to stop Covid vaccination
programs could be set higher. A more proportionate approach
might weigh the epidemiological and economic impact: Insurer
Allianz SE has estimated the cost of a five-week delay to the
EU’s economic reopening at 90 billion euros ($107 billion).
Europeans would do well to weigh the knock-on impact for
the rest of the world too, so soon after reaffirming the EU’s
commitment to sharing doses with developing countries via the
Covax multinational initiative and so soon after Italy blocked
exports of AstraZeneca doses to Australia to satisfy domestic
demand.
QuicktakeBlood Clots and Other Vaccine Fears
There are lessons here beyond vaccines. The plight of
European politicians seems to underscore what Harvard’s Cass
Sunstein once called the “paralyzing221; nature of the
precautionary principle, which can be invoked asboth an obstacle
to action as well as inaction. Or as one French public-health
expert put it bluntly, “A precautionary principle is something
you can apply when you don’t have a disease devastating the
planet.”
Take French President Emmanuel Macron’s foot-dragging over
whether to impose a new lockdown: What he and his advisers
consider as victories — another day or week without stay-at-home
curbs — may actually be prolonging the pain and delaying the
remedy. If U.K. Prime Minister Boris Johnson’s speed-first
vaccination drive is explicitly modeled on the Steven Soderbergh
movie “Contagion,221; Macron’s could be equated to Ingmar Bergman’s
“The Seventh Seal,” in which a knight plays chess with Death as
a plague rages.
A middle ground between throwing caution to the wind and
trying to avoidevery potential danger is possible. Leaders need
to stop ignoring the pandemicforest for the trees. That means
putting less focus on low-probability risks and taking a more
proportionate overall view of the trade-offs involved in delayed
or hesitant decision-making.
Better communication and data can help. Ruth Faden, who
founded the John Hopkins Berman Institute of Bioethics, says
collecting good-quality data on drug safety and side effects
around the world will be one way of improving decision-making
around vaccination campaigns. European leaders have much of this
in hand, and they should employ them to their advantage now.
Hopefully, regulators will draw a line under this issue in
the coming hours and days. But with billions of people around
the world due to be vaccinated, this has to be handled better
next time — because there will be a next time. Otherwise the
next conversation between Breton and Soriot will be a silent
one.

psychochopper
16/3/2021
11:30
CHELTENHAM
Anyone got the link to the racing tips board,

cm44
16/3/2021
11:03
Extrovert, they certainly should have, if not they will be looking a bit silly stood in the dole queue in their pin stripe suits :-)
optomistic
16/3/2021
11:01
So the Peoples Democratic Republic of Westminster want a US Style situation room and more nuclear weapons? Utter insanity, have they been binge watching box sets of 24?
Remember this at the ballot box, folks, if you vote for this take the consequences and don't moan about it later that you were lied to, how many warnings do you want?

minerve 2
16/3/2021
10:53
You can bet they have bought a shed load more at the lows.
extrovert
16/3/2021
10:29
Don't worry Little Englanders you will still be able to fill your face full of pasties and sausage rolls:

Bakery chain Greggs is to open 100 new shops in 2021 as it bets on a post-pandemic recovery.

minerve 2
16/3/2021
10:28
What a target...that should really please all the instis that took them off the govnt hands at 72p!!
optomistic
16/3/2021
09:57
CREDIT SUISSE RAISES LLOYDS PRICE TARGET TO 50 (44) PENCE - 'OUTPERFORM'
nick100
16/3/2021
09:32
In America in philadelphia you could be jailed if you bathed more than once a month
josh 32
Chat Pages: Latest  14040  14039  14038  14037  14036  14035  14034  14033  14032  14031  14030  14029  Older